PIK3CA-Related Overgrowth SpectrumSymptoms, Doctors, Treatments, Advances & More
Learn About PIK3CA-Related Overgrowth Spectrum
St. Christopher's Pediatric Associates Radiology - E. Erie Avenue
. Dr. Contrucci is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Tracheobronchopathia Osteoplastica, Scoliosis, Short Stature (Growth Disorders), and Familial Short Stature (FSS).
ETSU Pediatrics- St. Jude's Clinic
. Dr. Popescu is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Hereditary Spherocytosis, Von Willebrand Disease (VWD), Evans Syndrome, and Hemophilic Arthropathy.
Pediatrics Of Kingsport
I have wanted to be a pediatrician since I was a little girl. Interacting with children and their families, watching kids grow and making them well again are what I most value as a doctor. My personal philosophy is to always consider the whole person and to treat the patient, not the illness. I believe that parents have invaluable knowledge concerning their children and can offer great insight into what works best for them. My husband is an elementary school teacher, and we have three boys. Outside of work, I enjoy photography, hiking, biking and playing with my kids. In medical school, I was fortunate to do international mission work and hope to volunteer again as my kids grow. I am also interested in wellness promotion, including obesity prevention, promoting and supporting breastfeeding, and child abuse prevention. Dr. Terry is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Delayed Growth, Obesity in Children, Autism Spectrum Disorder, and Asthma in Children.
Summary: This study will examine rare congenital disorders that involve malformations and abnormal growth. It will focus on patients with Proteus syndrome, whose physical features are characterized by overgrowth, benign tumors of fatty tissue or blood vessels, asymmetric arms or legs, and large feet with very thick soles. The study will explore the genetic and biochemical cause and course of the disease, t...
Summary: This is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3CA Related Overgrowth Spectrum (PROS) and malformations driven by PIK3CA mutation. Part 1 is a dose selection, Part 2 is a basket design with exploratory single-arm cohorts for various subpopulations of participants, and Part 3 is randomize...